XLVLook at all your indicators on the weekly..
The Money flow , CCI , and Bollinger bands are my Favorite; all 3 are telling me a reversal is here..
Entry - over 125
Stop loss - 123.50
Target 130 then 134
XLV trade ideas
XLVThis is the second biggest sector and a big reason the Dow has been dumping.
Currently outside its daily Bollinger band and its weekly Money flow is oversold..
I'm expecting a major rally in Health this month
Let's see how XLV reacts after 126.50 gap close.. I'm not expecting a V shap recovery...
Maybe some around 126-128 to form a bullish pattern then we lift to resistance.
Wait for gap close
XLV. Health care sector about 🚀 Sizeable falling wedge ..
RSI is bullish
Entry Over - 133.50
Target 137
Stocks that will benefit from this
UNH
JNJ
PFE
2023 Market Crash2023 Market Crash
Is Confirmed.
You heard that right traders.
A consistent indicator over the past 20 years is confirming many fears of a recessions and market crash will occur in 2023.
DOUBLE BOTTOMS ON DAILY SET UP NICELY I mean just look at the technicalas, I don't really have to say much here lol. Maybe watch closely for rsi to hit bounce off 50 fist or just getttonninnn because this suckered has been rallying up like it's been in its own stock market this whole year.
XLV Short IdeaAfter regarding the 200SMA Daily as Resistance,
forms a Diamond Reversal w/ Triple MACD + RSI Hidden Bearish Divergence
w/ 4 Hour MACD Bearish Divergence
Looking for a breakout and to see how markets open this week before a final decision, loosen or tighten targets as you will.
GIVE ME FEEDBACK
** NOT FINANCIAL ADVICE **
$XLV - ~$147 by end of DecLooks primed for an extra 10% move up within 15-30 days starting since a few days now. See attached chart/image.
imgur.com
MACD / Price Divergence and Resistance Level on XLVAMEX:XLV
Price reaching a multiple test resistance level that goes back to end of April with a MACD / Price action divergence and MACD roll-over to negative.
XLV (Healthcare sector) Correction almost underwayIf you were trading tech and didn't notice , there was huge selling in the Healthcare sector , with most stocks down 4-7%.
This downturn was the main reason the Dow was down 300 points.
XLV is trading up in supply area and also forming a pretty decent size rising wedge which indicates the sector is near a correction.
I also saw alot of "Aero defense" selling to. Health care, Utilities and Aero defense were sectors investors flocked to for safety when rate increases started being announced, so I'm wondering is this just smart money rotating
back into growth or a the beginning of a larger overall market sell off?.
Here's a list of Stocks in this sector that will be exposed
www.marketwatch.com
XLV - Third Wave Down - ShortXLV has set up over the past few months and is now in a corrective wave, reached resistance and is headed down toward corrective wave C.
XLV headed to 117Second biggest sector in the S&P500 looks to be headed back to its primary trendline (Purpleline) after getting rejected on bear channel(Yellow) . This move should help push the S&P to low 340s.
Will have the biggest impact on Dow Jones because of United health
$XLV Potential 3-1-2 bearish Reversal on the Quarterly Chart$XLV is showing a potential 3-1-2 bearish reversal on the quarterly chart.
Because of this, I'll be looking to short healthcare stocks.
XLVStill holding $125 for now. Is price consolidating for a move higher or will the bearish divergence hold & make this a top?
XLV BUYSimply TA, XLV has been re-testing 124 support for past couple years now. Expect XLV to bounce at 124, if not, SL below 120 area, which has very high probability of holding.
SHORT | XLVAMEX:XLV
Possible Scenario: SHORT
Evidence: Price Action, Money-Flow, Rejection at 200MA,
TP1: 128$
TP1: 126$
This is my idea and could be wrong 100%.
RectangleNeutral pattern until a trendline is broken.
Bearish Marubozu with both ends shaven on Friday. Spinning top right now that can change by close.
No recommendation,
This ETF is still above the .382 of the trend up (blue dashed line)
Top 10 Holdings
UnitedHealth Group Inc
10.20%
Johnson & Johnson
9.21%
Pfizer Inc
5.68%
Eli Lilly and Co
5.21%
AbbVie Inc
5.08%
Thermo Fisher Scientific Inc
4.70%
Merck & Co Inc
4.53%
Abbott Laboratories
3.82%
Danaher Corp
3.78%
Bristol-Myers Squibb Co
3.15%
Healthcare staying sidewaysSafe bet when recession fears come in, cool off when good news give hope.
The health care sector ($XLV) is looking bullish!Notes:
* It seems like the health care sector is making an inverse head and shoulders pattern.
* A break out from this pattern could mean that health care stocks lead the market and the sector may see new all-time-highs.
* Be on the lookout for trade ideas in this sector as it's showing tonnes of accumulation recently
* You may also look to buy the sector ETF if it makes a daily close above the white trend line with higher than average volume.
Green in the sea of red: Healthcare (1)Summary
This week we are sharing 2 rebound trade opportunities in healthcare and biotech, AMEX:XLV and AMEX:XBI , which are showing relative strength against S&P500 and Nasdaq , making them better candidates to trade for rebound.
Since the beginning of 2022, skyrocketing inflation and increasing recession risk have pushed the broad equity markets to the downside. S&P500 is down more than 20% from peak, while the more tech heavy Nasdaq is down close to 30% from peak as of today. If we look back the whole rally, it all started during Mar-2020 as the Fed reacted aggressively toward covid by massive money printing (i.e. quantitative easing). In fact both S&P500 and Nasdaq are now getting closer to the 250 weeks moving average, which is approximately where the post-covid rally had broken the pre-covid peak. Rebound is very likely to happen as “where it started” is usually a strong resistance level that slows correction.
S&P500
Nasdaq100
To execute this trade, instead of directly longing the indexes, healthcare and biotech sector ETF, AMEX:XLV and AMEX:XBI are showing relative strength against S&P500 and Nasdaq100, which make them better candidates to trade the idea. Fundamentally speaking, we believe the reason behind the strength is due to the irreversible trends of aging population across the globe especially among developed countries; as well as in the seemingly more frequent pandemic outbreaks during recent years. Both trends create steady demand for healthcare and need for biotechnological innovation. The MRNA technology is a good recent example to illustrate the importance of biotechnological innovation in fighting pandemic.
We recommend more conservative traders to execute the idea with AMEX:XLV (this post), while more aggressive traders can go with AMEX:XBI (link here: ) which is relatively volatile.
Note : XBI also come with 3X leveraged ETF AMEX:LABU (bullish) and AMEX:LABD (bearish) for those who are looking for more leverage with same amount of capital
Technical
AMEX:XLV is still outperforming major indexes. Instead of downtrend, AMEX:XLV is still in a consolidation period. AMEX:XLV has been trading in extending box range since Oct-2021, with 1 extension to the upside in Dec-2021, and 1 extension to the downside this year on Jun-13.
The more than 8 months of consolidation period has flattened the 250 days moving average, yet not bending it downward (yet?). 20 days and 50 days moving averages have been crossing each other multiple times during the consolidation period, making them less indicative from a technical perspective. Currently AMEX:XLV is trading below 250 days moving average, tested but failed to penetrate the moving average on Jul-8, if it still cannot get above the 250 days moving average in the coming months, the downside pressure will materialize into an actual down trend.
In summary, these are the important levels one should pay attention to:
Downside support
118.75: Jun-13 new box bottom
109.74: Post covid peak before rallying to the upside
Upside resistance
132.04: Jul-8 attempt of breaking 250 days moving average
143.42: Apr-8 new box top
Healthcare sector - Buying the reversal of inverted HnSThe megaphone structure has completed the 5-wave structure and is likely to enter into the next phase of the bullish upside after a morning star candle formation is seen rebounding from the demand zone at 124.95. To add, the inverted head and shoulder pattern is indicative of a bullish reversal pattern.
$XLV:$KRE: Deflation winners and losersWe're seeing value health care ($XLV) show a lot of relative strength against other sectors as the dollar has been pushing. ($KRE) is often tied to growth when compared to it's bigger brother ($XLF) and eventhough financials do tend to benefit from rising rates, this has been much more of a hard landing and the financial rotation many expect may not come to pass, instead look for $XLV to continue soaking up 2022 when compared to other sectors.
